Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Acrivon Therapeutics, Inc.(ACRV US)

ProfileFinancialsChartingShort InterestEmployees

Overview

Profile

Financials & Metrics

FinancialsChartingShort InterestEmployees
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Acrivon Therapeutics, Inc.(ACRV US)

ProfileFinancialsChartingShort InterestEmployees

Overview

Profile

Financials & Metrics

FinancialsChartingShort InterestEmployees
ACRV US​
Ask AI
ACRV US​
Ask AI

Financials

Income Statement

Balance Sheet

Cash Flow
Millions USD (ex. Per Share)
FY202012/31/2020
FY202112/31/2021
FY202212/31/2022
FY202312/31/2023
FY202412/31/2024
FY202512/31/2025
Last 12M03/31/2026
Cash and Cash Equivalents36.039.841.534.1
Short Term Investments91.4139.777.163.7
Cash and Short Term Investments127.5179.5118.697.7
Net Receivables----
Inventory----
Other Current Assets2.22.11.91.5
Total Current Assets129.7181.6120.499.2
Property, Plant & Equipment7.98.07.46.9
Long Term Investments-5.1--
Other Non-Current Assets0.71.81.91.7
Total Non-Current Assets8.615.09.38.6
Total Assets138.3196.6129.7107.8
Account Payables5.00.82.31.2
Short Term Debt-1.1--
Deferred Revenue----
Other Current Liabilities3.95.55.62.2
Total Current Liabilities13.317.215.711.1
Long Term Debt---1.3
Other Non-Current Liabilities----
Total Non-Current Liabilities3.82.61.51.3
Total Liabilities17.119.817.212.3
Common Stock0.00.00.00.0
Retained Earnings-116.4-197.0-274.9-293.9
Total Stockholders Equity121.2176.8112.595.5
Total Liabilities and Equity138.3196.6129.7107.8

Financials

Income Statement

Balance Sheet

Cash Flow
Millions USD (ex. Per Share)
FY202012/31/2020
FY202112/31/2021
FY202212/31/2022
FY202312/31/2023
FY202412/31/2024
FY202512/31/2025
Last 12M03/31/2026
Cash and Cash Equivalents36.039.841.534.1
Short Term Investments91.4139.777.163.7
Cash and Short Term Investments127.5179.5118.697.7
Net Receivables----
Inventory----
Other Current Assets2.22.11.91.5
Total Current Assets129.7181.6120.499.2
Property, Plant & Equipment7.98.07.46.9
Long Term Investments-5.1--
Other Non-Current Assets0.71.81.91.7
Total Non-Current Assets8.615.09.38.6
Total Assets138.3196.6129.7107.8
Account Payables5.00.82.31.2
Short Term Debt-1.1--
Deferred Revenue----
Other Current Liabilities3.95.55.62.2
Total Current Liabilities13.317.215.711.1
Long Term Debt---1.3
Other Non-Current Liabilities----
Total Non-Current Liabilities3.82.61.51.3
Total Liabilities17.119.817.212.3
Common Stock0.00.00.00.0
Retained Earnings-116.4-197.0-274.9-293.9
Total Stockholders Equity121.2176.8112.595.5
Total Liabilities and Equity138.3196.6129.7107.8